Tag: precision medicine
June 28, 2018
5 Top NASDAQ Genetic Stocks of Q2 2018
In the final days of Q2 2018, we've profiled the five top NASDAQ genetic stocks year-to-date. Here's a look at... May 9, 2018
ARCA Biopharma announces first quarter 2018 financial results AND Provides Corporate Update
ARCA biopharma (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today reported... April 19, 2018
OpGen Completes Rapid Testing Clinical Trial in Colombia and Expands International Operations
OpGen (NASDAQ:OPGN) OpGen announced today that it successfully completed a prospective clinical trial evaluating the impact of using rapid diagnostic... April 16, 2018
Cancer Genetics’ Unique Tissue of Origin Test Receives Special FDA 510(k) Clearance
Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced that it...
April 12, 2018
Illumina and Loxo Oncology Form Collaboration, Share Prices Increase
Illumina and Loxo have teamed up to develop and commercialize a multi-gene panel for broad tumor profiling for cancer indications. April 10, 2018
Loxo Oncology and Illumina to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics
Loxo Oncology (Nasdaq:LOXO) and Illumina (Nasdaq:ILMN) announced a global strategic partnership to develop and commercialize a multi-gene panel for broad... April 3, 2018